Home > Insider Trading > Filing (0001209191-19-054525)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783183	Phathom Pharmaceuticals Inc.	PHAT	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1341382	N James Topper	C/O Phathom Pharmaceuticals, Inc. 2150 E. Lake Cook Road, Suite 800 Buffalo Grove IL 60089	Yes	No	Yes	No
1365617	J Patrick Heron	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1720320	Frazier Life Sciences Ix, L.p.	601 Union Street Suite 3200 Seattle WA 98101	No	No	Yes	No
1782789	Fhmls Ix, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1782791	Fhmls Ix, L.l.c.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-29	1,353,640	$15.20	6,231,638	No	4	C	Direct
Common Stock	Acquisiton	2019-10-29	1,052,631	$19.00	7,284,269	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Notes	Disposition	2019-10-29	0	$0.00	1,353,640	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-05-07	No	4	C	Direct

Footnotes

Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock based on a conversion price of $15.20 per share.
The shares reported herein are held of record by Frazier Life Sciences IX, L.P. ("FLS IX"). The general partner of FLS IX is FHMLS IX, L.P., and the general partner of FHMLS IX, L.P. is FHMLS IX, L.L.C. James Topper and Patrick Heron are the sole managing members of FHMLS IX, L.L.C. and share voting and investment power of the securities held by FLS IX. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.